Dealing with in-stent restenosis

Heart

Volumn 79, Issue 4, 1998, Pages 319-323

  Gershlick, A H ^a   Baron, J ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATHERECTOMY; INCIDENCE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RESTENOSIS; REVIEW; STENT; VEIN GRAFT;

EID: 0031966078     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.79.4.319     Document Type: Review

References (24)

1. van Beusekom HM, van der Giessen, van Suylen R, et al. Histology after stenting of human saphenous vein bypass grafts: observations from surgically excised grafts 3-320 days after stent implantation. J Am Coll Cardiol 1993;21:45-54.
2. Carter AJ, Laird JR, Farb A, et al. Morphological characteristics of lesion formation and time course of smooth muscle cell proliferation in a porcine proliferative restenosis model. J Am Coll Cardiol 1994;24:1398-405.
3. Dussaillant GR, Mintz GS, Pichard AD, et al. Small stent size and intimai hyperplasia contribute to restenosis; a volumetric intravascular ultrasound analysis. J Am Coll Cardiol 1995;26:720-4.
4. Califf RM, the EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-61.
5. Mehran R, Mintz GS, Popma JJ, et al. treatment of in-stent restenosis: an intravascular ultrasound study of results in 159 stented lesions [abstract]. J Am Coll Cardiol 1997;29: 77A.
6. Yokoi H, Kimura T, Nakagawa Y, et al. Long-term clinical and quantitative angiographic follow-up after the Palmaz-Schatz. J Am Coll Cardiol 1996;272(2 suppl A):224A.
7. Baim DS, Lavine MJ, Leon MB, et al. Management of restenosis within the Palmaz-Schatz coronary artery stent (the US multicenter experience). Am J Cardiol 1993;71:364-6.
8. Tan H, Sketch MH, Tan M, et al. Is there an optimal treatment strategy for stent restenosis? [abstract] Circulation 1996;94:I-91.
9. Sharma S, Duvvuri S, Kakarala V, et al, Rotational atherectomy (RA) for in-stent restenosis (ISR): intravascular ultrasound (IVUS) and quantitative coronary analysis (QCA) [abstract]. Circulation 1996;94:I-454.
10. Buchbinder M Goldberg SL, Fortuna RF, et al. Rotational atherectomy for intra-stent stenosis: initial experience. Circulation 1996;94:I-621.
11. Fischell TA. Polymer coatings for stents. Can we judge a stent by its cover? Circulation 1996;94:1494-5.
12. Van der Giessen WJ, Lincoff AM, Schwanz RS, et al. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 1996;94:1690-7.
13. King SB III. Intravascular radiation for restenosis prevention: could it be the holy grail? Heart 1996;76:99-100.
14. Fischell TA, Kharma BK, Fischell DR, et al. Low dose, beta-particle emission from "stent" wires results in complete, localized inhibition of smooth muscle cell proliferation. Circulation 1994;90:2956-63.
15. Waksman R, Robinson KA, Crocker IR, et al. Intravascular radiation before stent implantation inhibits neointimal formation in stented porcine coronary arteries. Circulation 1995;93:1383-6.
16. Carter AJ, Laird JR, Bailley LR, et al. Effets of endovascular radiation from a beta-particle emitting stent in a porcine coronary stenosis model. A dose response study. Circulation 1996;94:2364-8.
17. Popowski Y, Venn V, Urban P. Endovascular beta-irradiation after percutaneous transluminal coronary balloon angioplasty. Int J Radiat Oncol 1994;36:841-5.
18. Teirsten PS, Massuillo V, Jani S, et al. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med 1997;336:1697-703.
19. Mazur W, Ali MN, Khan MM, et al. High dose intracoronary radiation for inhibition of neointimal formation in the stented and balloon injured porcine models of restenosis; angiographic, morphometric, and histopathologic analyses. Int J Radiat Oncol 1996;36:777-88.
20. Serruys PW, Emanuelsson H, van der Giessen W, et al. Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the Benestent II pilot study. Circulation 1996;93:412-22.
21. Aggarwal RK, Ireland DC, Azrin MA, et al. Antithrombotic potential of polymer-coated stents eluting platelet glycoprotein IIb/IIIa receptor antibody. Circulation 1996;94: 3311-17.
22. Matsuno H, Stassen JM, Vermylen J, et al. Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation. Circulation 1994;90:2203-6.
23. Baron JH, Aggrawal R, de Bono DP, et al. Adsorption and elution of c7E3 Fab from polymer coated stents in-vitro [abstract]. Eur Heart J 1997;18:503.
24. Baron JH, de Bono DP, Gershlick AH. c7E3 Fab inhibits adhesion of smooth muscle cells to vitronectin: a possible way of inhibiting in-stent restenosis [abstract]. Eur Heart J 1997;18:500.